These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36331561)
1. Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy. Lee YJ; Jeon HY; Lee AJ; Kim M; Ha KS FASEB J; 2022 Dec; 36(12):e22643. PubMed ID: 36331561 [TBL] [Abstract][Full Text] [Related]
2. Pericyte loss via glutaredoxin2 downregulation aggravates diabetes-induced microvascular dysfunction. Li C; Chen X; Zhang S; Liang C; Deng Q; Li X; Yan H Exp Eye Res; 2024 Oct; 247():110025. PubMed ID: 39117135 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous attenuation of hyperglycemic memory-induced retinal, pulmonary, and glomerular dysfunctions by proinsulin C-peptide in diabetes. Jeon HY; Moon CH; Kim EB; Sayyed ND; Lee AJ; Ha KS BMC Med; 2023 Feb; 21(1):49. PubMed ID: 36782199 [TBL] [Abstract][Full Text] [Related]
4. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
5. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy. Kim D; Mecham RP; Nguyen NH; Roy S Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398 [TBL] [Abstract][Full Text] [Related]
6. NADH-Cytochrome B5 reductase 2 suppresses retinal vascular dysfunction through regulation of vascular endothelial growth factor A in diabetic retinopathy. Chen J; Sun Y; Chen L; Zhou Y Exp Eye Res; 2022 Sep; 222():109186. PubMed ID: 35820466 [TBL] [Abstract][Full Text] [Related]
7. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling. Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105 [TBL] [Abstract][Full Text] [Related]
8. M2 microglia-derived exosomes promote vascular remodeling in diabetic retinopathy. Wang X; Xu C; Bian C; Ge P; Lei J; Wang J; Xiao T; Fan Y; Gu Q; Li HY; Xu J; Hu Z; Xie P J Nanobiotechnology; 2024 Feb; 22(1):56. PubMed ID: 38336783 [TBL] [Abstract][Full Text] [Related]
9. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Witmer AN; van den Born J; Vrensen GF; Schlingemann RO Curr Eye Res; 2001 Mar; 22(3):190-7. PubMed ID: 11462155 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
11. Systemic C-peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF-induced pathological events in diabetes. Lee AJ; Moon CH; Lee YJ; Jeon HY; Park WS; Ha KS FASEB J; 2023 Feb; 37(2):e22763. PubMed ID: 36625326 [TBL] [Abstract][Full Text] [Related]
12. Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina. Qiu Y; Zhao D; Butenschön VM; Bauer AT; Schneider SW; Skolnik EY; Hammes HP; Wieland T; Feng Y Acta Diabetol; 2016 Feb; 53(1):81-9. PubMed ID: 25900369 [TBL] [Abstract][Full Text] [Related]
13. LECT2 Ameliorates Blood-Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway. Qin YJ; Xiao K; Zhong Z; Zhao Y; Yu T; Sun XF Invest Ophthalmol Vis Sci; 2022 Mar; 63(3):7. PubMed ID: 35262733 [TBL] [Abstract][Full Text] [Related]
14. Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy. Elmasry K; Ibrahim AS; Saleh H; Elsherbiny N; Elshafey S; Hussein KA; Al-Shabrawey M Diabetologia; 2018 May; 61(5):1220-1232. PubMed ID: 29468369 [TBL] [Abstract][Full Text] [Related]
15. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats. Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985 [TBL] [Abstract][Full Text] [Related]
16. Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice. Lim YC; Bhatt MP; Kwon MH; Park D; Lee S; Choe J; Hwang J; Kim YM; Ha KS Cardiovasc Res; 2014 Jan; 101(1):155-64. PubMed ID: 24142430 [TBL] [Abstract][Full Text] [Related]
17. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Behl Y; Krothapalli P; Desta T; DiPiazza A; Roy S; Graves DT Am J Pathol; 2008 May; 172(5):1411-8. PubMed ID: 18403591 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of fibrillin-1 suppresses retina-blood barrier dysfunction by inhibiting vascular endothelial apoptosis under diabetic conditions. Zhang Y; Liu XJ; Zhai XR; Yao Y; Shao B; Zhen YH; Zhang X; Xiao Z; Wang LF; Zhang ML; Chen ZM Int J Ophthalmol; 2024; 17(8):1403-1410. PubMed ID: 39156790 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Drp1 ameliorates diabetic retinopathy by regulating mitochondrial homeostasis. Zhang MY; Zhu L; Bao X; Xie TH; Cai J; Zou J; Wang W; Gu S; Li Y; Li HY; Yao Y; Wei TT Exp Eye Res; 2022 Jul; 220():109095. PubMed ID: 35490835 [TBL] [Abstract][Full Text] [Related]